CLINI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 40.311
AS - Asia 21.915
EU - Europa 19.190
SA - Sud America 3.523
AF - Africa 551
OC - Oceania 383
Continente sconosciuto - Info sul continente non disponibili 25
AN - Antartide 1
Totale 85.899
Nazione #
US - Stati Uniti d'America 39.469
SG - Singapore 6.124
CN - Cina 5.932
IT - Italia 4.916
GB - Regno Unito 4.772
HK - Hong Kong 2.848
BR - Brasile 2.571
VN - Vietnam 2.249
DE - Germania 1.941
SE - Svezia 1.665
FI - Finlandia 1.161
FR - Francia 855
RU - Federazione Russa 809
UA - Ucraina 762
KR - Corea 737
IN - India 651
TR - Turchia 646
ID - Indonesia 561
CA - Canada 448
BG - Bulgaria 359
NL - Olanda 351
JP - Giappone 343
AU - Australia 332
AR - Argentina 303
BD - Bangladesh 279
MX - Messico 274
IE - Irlanda 243
ES - Italia 204
PK - Pakistan 185
IQ - Iraq 177
CO - Colombia 165
PL - Polonia 154
ZA - Sudafrica 150
CL - Cile 146
IR - Iran 138
AE - Emirati Arabi Uniti 128
TW - Taiwan 118
EC - Ecuador 117
PH - Filippine 111
RO - Romania 110
AT - Austria 106
DK - Danimarca 100
MY - Malesia 95
BE - Belgio 92
TH - Thailandia 91
EG - Egitto 87
LT - Lituania 81
CH - Svizzera 78
SA - Arabia Saudita 78
VE - Venezuela 72
PT - Portogallo 68
MA - Marocco 64
PE - Perù 63
GR - Grecia 56
CZ - Repubblica Ceca 52
UZ - Uzbekistan 51
JO - Giordania 50
NZ - Nuova Zelanda 45
SI - Slovenia 45
PY - Paraguay 42
NO - Norvegia 41
NP - Nepal 39
KE - Kenya 38
IL - Israele 37
TN - Tunisia 37
DZ - Algeria 35
LB - Libano 29
UY - Uruguay 29
CR - Costa Rica 27
AZ - Azerbaigian 26
KZ - Kazakistan 24
HU - Ungheria 23
DO - Repubblica Dominicana 20
ET - Etiopia 19
OM - Oman 19
RS - Serbia 19
AL - Albania 17
BH - Bahrain 16
HR - Croazia 16
NG - Nigeria 16
SK - Slovacchia (Repubblica Slovacca) 16
GE - Georgia 15
GH - Ghana 15
KG - Kirghizistan 15
PA - Panama 15
PS - Palestinian Territory 15
SN - Senegal 15
BO - Bolivia 12
EE - Estonia 12
SY - Repubblica araba siriana 12
LK - Sri Lanka 11
BY - Bielorussia 10
EU - Europa 10
QA - Qatar 10
BF - Burkina Faso 9
IS - Islanda 9
JM - Giamaica 9
MD - Moldavia 9
MK - Macedonia 9
TT - Trinidad e Tobago 9
Totale 85.684
Città #
Fairfield 4.499
Singapore 3.994
Ashburn 3.675
Santa Clara 3.549
Hong Kong 2.774
Southend 2.613
Woodbridge 2.364
Houston 2.116
Hefei 2.092
Chandler 1.898
Seattle 1.601
Cambridge 1.465
Jacksonville 1.444
Wilmington 1.443
London 1.110
Dearborn 1.056
San Jose 981
Beijing 914
Ann Arbor 904
Helsinki 827
Nyköping 799
Council Bluffs 769
Ho Chi Minh City 700
Seoul 634
Los Angeles 612
The Dalles 609
Chicago 601
San Diego 582
Hanoi 543
New York 490
Milan 454
Princeton 408
Modena 393
Jakarta 385
Sofia 339
Lauterbourg 333
Grafing 325
Rome 275
Eugene 273
Moscow 267
Shanghai 248
Izmir 242
Redwood City 236
São Paulo 234
Buffalo 229
Salt Lake City 210
Bologna 208
Tokyo 199
Dallas 182
Munich 182
Dublin 177
Frankfurt am Main 135
Columbus 125
Orem 122
Des Moines 115
Elk Grove Village 106
Da Nang 104
Naples 101
Tampa 93
Chennai 90
Guangzhou 90
Phoenix 90
Warsaw 89
Dong Ket 88
Kent 88
Boardman 87
Toronto 87
Nuremberg 86
Haiphong 82
Sydney 82
Mexico City 79
Denver 78
Rio de Janeiro 78
Amsterdam 77
Parma 76
Lappeenranta 75
Atlanta 74
Melbourne 72
Montreal 72
Mumbai 71
Florence 70
Ankara 68
Norwalk 68
Belo Horizonte 67
Nanjing 67
Verona 67
Santiago 66
Bremen 64
Esbjerg 63
Winnipeg 63
Johannesburg 62
Paris 62
Baghdad 61
Redondo Beach 61
Turin 61
Brooklyn 60
Istanbul 59
Miami 59
Hangzhou 57
Curitiba 55
Totale 57.329
Nome #
An Italian consensus on pulmonary rehabilitation in COVID-19 patients recovering from acute respiratory failure: results of a Delphi process 2.631
Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. 514
European Respiratory Society Guideline on Long-term Home Non-Invasive Ventilation for Management of Chronic Obstructive Pulmonary Disease. 505
Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer 450
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 444
An Official American Thoracic Society / European Respiratory Society Statement: Key concepts and advances in pulmonary rehabilitation - An Executive Summary. 424
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 424
High flow oxygen therapy during exercise training in COPD patients with chronic respiratory failure: a multicenter randomised trial. 422
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 394
Insufficienza respiratoria acuta e cronica (cap.21). 385
Chronic respiratory abnormalities in the multi-morbid frail elderly 380
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 378
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 371
Acute severe asthma: management and treatment. 368
Delirium and risk factors in patients undergoing non-invasive ventilation for de novo acute respiratory failure: an observational multicenter trial. 363
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 362
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 360
An uncommon cause of hemoptysis: aortobronchial fistula. 352
Manuale di Pneumologia 350
Effects of a walking aid in COPD patients receiving oxygen therapy 349
Advances in Ambulatory Oxygen workshop and Longterm Oxygen therapy in real-life practice. 348
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 345
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 344
Pulmonary rehabilitation following radical chemo-radiation in locally-advanced non surgical NSCLC: preliminary evidences. 339
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 338
Integrating the care of the complex COPD patient 332
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 331
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 330
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 329
An uncommon cause of pneumonia: The golden diagnosis 327
La broncopneumopatia cronica ostruttiva nell'anziano 327
Incidence, etiology and clinico-pathologic features of endobronchial benign lesions: 10 consecutive years rerospective study 326
Spontaneous breathing and evolving phenotypes of lung damage in patients with COVID-19. 326
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 323
A Prospective Multicentric Study of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease and Different Clinical Phenotypes 322
Effect of rehabilitative exercise training on peripheral muscle remodelling in patients with COPD: targeting beyond the lungs 321
Prevalence and outcome of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of chronic obstructive pulmonary disease: a pilot study. 316
Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation. 316
A case of dyspnea: respiratory failure due to pulmonary arteriovenous malformation 314
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 311
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 311
8th international conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 1 309
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults 307
LABA/LAMA fixed dose combinations in patients with COPD: a systematic review 304
Advanced COPD patients under home mechanical ventilation and/or long term oxygen therapy: Italian healthcare costs 300
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 299
Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting 299
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 299
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 298
Insufficienza Respiratoria acuta e cronica (cap.21). 297
8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – Part 3 297
Chronic critical illness: the price of survival 295
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 295
Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases. 291
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 290
Learning impact of education during pulmonary rehabilitation program. An observational short-term cohort study 289
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 287
8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 2 287
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 286
Activity and analysis of costs in a dedicated weaning centre 281
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 281
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 280
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 279
A core syllabus for postgraduate training in respiratory physiotherapy. 279
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study 278
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 278
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 277
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease. 274
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 272
COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply. 271
Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients. 270
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 270
An official American Thoracic Society/European Respiratory Society policy statement: Enhancing implementation, use, and delivery of pulmonary rehabilitation 269
Looking for a Chronic Care Model in COPD patients 267
Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency. 266
Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation. 265
Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. 264
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 264
Subjective sleep quality during average volume assured pressure support (AVAPS) ventilation in patients with hypercapnic COPD: A physiological pilot study 263
A conceptual framework for reporting experience with physical activity in COPD. 263
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 263
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 263
GOLD 2017 recommendations for COPD patients: toward a more personalized approach 262
Pulmonary Rehabilitation 261
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 261
Long-term tracheostomy in severe COPD patients weaned from mechanical ventilation. 260
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 259
COVIDGuide una app per il triage e l'autovalutazione della COVID-19. 259
Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: effect of docosahexaenoic acid supplementation. 256
Maximal inspiratory and expiratory pressure measurement in tracheotomised patients 255
The encaged lung: rapidly progressive idiopathic pleurisy. 255
Commencing rehabilitation in the ICU. 254
Dynamic Hyperinflation is Associated with a Poor Cardiovascular Response to Exercise in COPD Patients. 254
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 253
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 251
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 251
Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes. 247
Atypical diagnosis for typical lung carcinoid 245
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 245
Never Give Up: lesson learned from a severe COVID-19 patient. 244
Totale 33.240
Categoria #
all - tutte 341.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 341.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.349 0 0 0 0 0 0 0 0 0 968 740 641
2021/20228.504 639 823 768 565 333 444 797 460 973 622 1.241 839
2022/20236.569 759 657 415 555 732 945 182 669 883 142 343 287
2023/20245.273 229 327 322 507 845 468 566 604 212 223 338 632
2024/202515.579 485 268 316 1.145 2.488 2.298 1.447 889 1.754 696 1.664 2.129
2025/202626.161 2.007 1.431 2.969 3.684 3.579 2.339 3.547 1.636 2.665 2.304 0 0
Totale 86.834